Journal
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 23, Issue 15, Pages 4172-4180Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2015.06.053
Keywords
Imidazole; 1,3,4-Oxadiazole; Pyridine; Antifungal activity; Docking
Funding
- Fundo Europeu de Desenvolvimento Regional-QREN-COMPETE of Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/AAC-CLI/118092/2010]
- Centro de Quimica de Coimbra (CQC), FCTUC
- [SFRH/BPD/86581/2012]
- [Pest-C/QUI/UI0313/2011]
- [PEst-OE/QUI/UI0313/2014]
- Fundação para a Ciência e a Tecnologia [PEst-OE/QUI/UI0313/2014, PEst-C/QUI/UI0313/2011, PTDC/AAC-CLI/118092/2010] Funding Source: FCT
Ask authors/readers for more resources
A series of compounds in which 2-(4-ethyl-2-pyridyl)-1H-imidazole was clubbed with substituted 1,3,4-oxadiazole was synthesized and subjected to antifungal activity evaluation. In vitro assays indicated that several clubbed derivatives had excellent antifungal activity against different strains of laboratory and clinically isolated Candida species. Structural Activity Relationship (SAR) studies revealed that the presence and position of substituents on the phenyl ring of the 1,3,4-oxadiazole unit, guides the antifungal potential of the compounds, where compound 4b, 4c and 4g were found to be active against all the tested fungal strains. Impairment of ergosterol biosynthesis upon the concomitant treatment of 4b, 4c and 4g, revealed the possible mechanisms of antifungal action of these compounds. Inhibitors snugly fitting the active site of the target enzyme, as revealed by molecular docking studies, may well explain their excellent inhibitory activity. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available